<VariationArchive RecordType="classified" VariationID="526504" VariationName="NC_000016.10:g.(?_89761943)_(89920218_?)del" VariationType="Deletion" Accession="VCV000526504" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2020-04-09" MostRecentSubmission="2020-04-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="529286" VariationID="526504">
      <GeneList>
        <Gene Symbol="LOC130059839" FullName="ATAC-STARR-seq lymphoblastoid silent region 7925" GeneID="130059839" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89816151" stop="89816200" display_start="89816151" display_stop="89816200" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130059840" FullName="ATAC-STARR-seq lymphoblastoid active region 11422" GeneID="130059840" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89817261" stop="89817310" display_start="89817261" display_stop="89817310" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130059841" FullName="ATAC-STARR-seq lymphoblastoid silent region 7927" GeneID="130059841" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89828529" stop="89828618" display_start="89828529" display_stop="89828618" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130059842" FullName="ATAC-STARR-seq lymphoblastoid active region 11423" GeneID="130059842" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89861068" stop="89861157" display_start="89861068" display_stop="89861157" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130059843" FullName="ATAC-STARR-seq lymphoblastoid active region 11424" GeneID="130059843" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89864260" stop="89864339" display_start="89864260" display_stop="89864339" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130059844" FullName="ATAC-STARR-seq lymphoblastoid active region 11425" GeneID="130059844" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89864400" stop="89864489" display_start="89864400" display_stop="89864489" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130059845" FullName="ATAC-STARR-seq lymphoblastoid silent region 7928" GeneID="130059845" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89873317" stop="89873436" display_start="89873317" display_stop="89873436" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130059846" FullName="ATAC-STARR-seq lymphoblastoid silent region 7929" GeneID="130059846" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89873907" stop="89874376" display_start="89873907" display_stop="89874376" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC132090451" FullName="Neanderthal introgressed variant-containing enhancer experimental_46779" GeneID="132090451" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89822193" stop="89822362" display_start="89822193" display_stop="89822362" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC132090890" FullName="Neanderthal introgressed variant-containing enhancer experimental_46826" GeneID="132090890" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89882492" stop="89882661" display_start="89882492" display_stop="89882661" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="MC1R" FullName="melanocortin 1 receptor" GeneID="4157" HGNC_ID="HGNC:6929" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89918862" stop="89920972" display_start="89918862" display_stop="89920972" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="89984286" stop="89987384" display_start="89984286" display_stop="89987384" Strand="+" />
          </Location>
          <OMIM>155555</OMIM>
        </Gene>
        <Gene Symbol="LOC130059838" FullName="ATAC-STARR-seq lymphoblastoid active region 11421" GeneID="130059838" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89765240" stop="89765309" display_start="89765240" display_stop="89765309" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="FANCA" FullName="FA complementation group A" GeneID="2175" HGNC_ID="HGNC:3582" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89737549" stop="89816647" display_start="89737549" display_stop="89816647" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="89803958" stop="89883064" display_start="89803958" display_stop="89883064" Strand="-" />
          </Location>
          <OMIM>607139</OMIM>
        </Gene>
        <Gene Symbol="LOC112486223" FullName="Sharpr-MPRA regulatory region 3988" GeneID="112486223" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89816431" stop="89816875" display_start="89816431" display_stop="89816875" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC125177396" FullName="Sharpr-MPRA regulatory region 15702" GeneID="125177396" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89910221" stop="89910515" display_start="89910221" display_stop="89910515" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC126862451" FullName="BRD4-independent group 4 enhancer GRCh37_chr16:89900233-89901432" GeneID="126862451" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89833825" stop="89835024" display_start="89833825" display_stop="89835024" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC128772421" FullName="melanoma risk locus-associated MPRA allelic enhancer 16:89913406" GeneID="128772421" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89846928" stop="89847072" display_start="89846928" display_stop="89847072" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130059837" FullName="ATAC-STARR-seq lymphoblastoid active region 11420" GeneID="130059837" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89764970" stop="89765079" display_start="89764970" display_stop="89765079" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="SPIRE2" FullName="spire type actin nucleation factor 2" GeneID="84501" HGNC_ID="HGNC:30623" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89828475" stop="89871319" display_start="89828475" display_stop="89871319" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="89894906" stop="89937726" display_start="89894906" display_stop="89937726" Strand="+" />
          </Location>
          <OMIM>609217</OMIM>
        </Gene>
        <Gene Symbol="TCF25" FullName="transcription factor 25" GeneID="22980" HGNC_ID="HGNC:29181" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89873592" stop="89911379" display_start="89873592" display_stop="89911379" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="89939993" stop="89977791" display_start="89939993" display_stop="89977791" Strand="+" />
          </Location>
          <OMIM>612326</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000016.10:g.(?_89761943)_(89920218_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" innerStart="89761943" innerStop="89920218" display_start="89761943" display_stop="89920218" variantLength="158276" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" innerStart="89828351" innerStop="89986626" display_start="89828351" display_stop="89986626" variantLength="158276" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.(?_89761943)_(89920218_?)del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.(?_89761943)_(89920218_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.(?_89828351)_(89986626_?)del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.(?_89828351)_(89986626_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000016.10:g.(?_89761943)_(89920218_?)del AND Fanconi anemia" Accession="RCV000631041" Version="2">
        <ClassifiedConditionList TraitSetID="6447">
          <ClassifiedCondition DB="MedGen" ID="C0015625">Fanconi anemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-05-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-05-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-09" MostRecentSubmission="2020-04-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="6447" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1797" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Fanconi anemia</ElementValue>
                <XRef ID="MONDO:0019391" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS227650" DB="OMIM" />
                <XRef ID="84" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fanconi pancytopenia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fanconi's anemia</ElementValue>
                <XRef ID="Fanconi+Anemia/2780" DB="Genetic Alliance" />
                <XRef ID="30575002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FA</ElementValue>
                <XRef Type="MIM" ID="227650" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Fanconi anemia (FA) is characterized by physical abnormalities, bone marrow failure, and increased risk for malignancy. Physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies. Progressive bone marrow failure with pancytopenia typically presents in the first decade, often initially with thrombocytopenia or leukopenia. The incidence of acute myeloid leukemia is 13% by age 50 years. Solid tumors – particularly of the head and neck, skin, and genitourinary tract – are more common in individuals with FA.</Attribute>
                <XRef ID="NBK1401" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6425" />
                <XRef ID="6425" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301575</ID>
                <ID Source="BookShelf">NBK1401</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="PubMed">18197057</ID>
                <ID Source="pmc">3110977</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2009">
                <ID Source="PubMed">19888064</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="FARF, 2008">
                <URL>http://www.fanconi.org/images/uploads/other/Guidelines_for_Diagnosis_and_Management.pdf</URL>
                <CitationText>Fanconi Anemia Research Fund, Guidelines for Diagnosis and Management, 2008 (See 2020 Update)</CitationText>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Breast and Gynecologic Cancers">
                <ID Source="PubMed">26389210</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="FARF, 2020">
                <URL>https://www.fanconi.org/images/uploads/other/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.pdf</URL>
                <CitationText>Fanconi Anemia Clinical Care Guidelines, Fifth Edition.</CitationText>
              </Citation>
              <XRef ID="84" DB="Orphanet" />
              <XRef ID="C0015625" DB="MedGen" />
              <XRef ID="D005199" DB="MeSH" />
              <XRef ID="MONDO:0019391" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS227650" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1461452" SubmissionDate="2020-02-06" DateLastUpdated="2020-04-09" DateCreated="2018-05-28">
        <ClinVarSubmissionID localKey="2938297|MedGen:C0015625" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000752025" DateUpdated="2020-04-09" DateCreated="2018-05-28" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is a gross deletion of the genomic region encompassing exons 1-29 of the FANCA gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 29 of the FANCA gene. This is expected to result in an absent or disrupted protein product. This variant has not been reported in the literature in individuals with FANCA-related disease. Loss-of-function variants in FANCA are known to be pathogenic (PMID: 19367192). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FANCA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.(?_89828351)_(89986626_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Fanconi anemia</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0015625" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1461452" TraitType="Disease" MappingType="Name" MappingValue="Fanconi anemia" MappingRef="Preferred">
        <MedGen CUI="C0015625" Name="Fanconi anemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

